Article Figures & Data
Figures
- Figure 1.
The graph shows accumulation of protoporphyrin IX (PpIX) in C2C12 and HT1080 cells after 24 h (A) and 48 h (B) of treatment. The accumulation of PpIX in HT 1080 is significantly higher than that in C2C12 after 24 h (A) and 48 h (B) of treatment (**p<0.01). (Black bar; C2C12, Gray bar; HT1080).
- Figure 2.
Western blotting shows weak expression of ferrochelatase (FECH) in sarcoma cell lines compared to that in C2C12 cells.
- Figure 3.
The cell proliferation assay showed significant inhibition of cell proliferation in the 100 and 200 μg/ml 5-Aminolevulinic acid (5-ALA) photodynamic therapy (PDT) group groups compared to the group treated with 0 μg/ml 5-ALA PDT at 48 h in 143B (A), LM8 (B), and HT1080 (C) (*p<0.05). (A: 0 μg/ml 5-ALA, B: 10 μg/ml 5-ALA, C: 100 μg/ml 5-ALA, D: 200 μg/ml 5-ALA).
- Figure 4.
The 5-Aminolevulinic acid (5-ALA) photodynamic therapy (PDT) group shows a significant inhibition in tumor volume compared with that in the control, 5-ALA alone, and strobe scope light alone groups at 14 days after treatment (A: 143B cells, B: LM8 cells, C: HT1080cells) (*p<0.05, **p<0.01). (A: control, B: 250 mg/kg 5-ALA, C: strobe scope light, D: 5-ALA PDT).
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.